|
1
|
Small-airway obstruction and emphysema in chronic obstructive pulmonary disease.
|
N Engl J Med
|
2011
|
4.16
|
|
2
|
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.
|
Blood
|
2013
|
2.91
|
|
3
|
Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
|
Arch Pathol Lab Med
|
2012
|
2.46
|
|
4
|
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer.
|
J Clin Invest
|
2014
|
1.33
|
|
5
|
A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions.
|
Mol Ther
|
2010
|
1.15
|
|
6
|
Evaluation of an attenuated vesicular stomatitis virus vector expressing interferon-beta for use in malignant pleural mesothelioma: heterogeneity in interferon responsiveness defines potential efficacy.
|
Hum Gene Ther
|
2010
|
1.14
|
|
7
|
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma.
|
Am J Respir Crit Care Med
|
2011
|
1.07
|
|
8
|
TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems.
|
Int J Gynecol Pathol
|
2009
|
0.97
|
|
9
|
Adjuvant radiotherapy for completely resected stage 2 thymoma.
|
Cancer
|
2011
|
0.90
|
|
10
|
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma.
|
J Thorac Oncol
|
2013
|
0.78
|